COMMUNIQUÉS West-GlobeNewswire

Nightstar Therapeutics plc Court Approval Received in Connection With Acquisition by Biogen
05/06/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect
05/06/2019
Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain NanoVibronix partnering with Saralex Group for regulatory approval and global [...]
Flexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of Osteoarthritis
05/06/2019
BURLINGTON, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Patent and Trademark Office (USPTO) has issued patent number 10,301,645 for FX201, the company' [...]
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
05/06/2019
MaxHealth to distribute Biomerica’s colorectal screening test to help identify the early warning signs of colorectal cancer. IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it [...]
Xenon Pharmaceuticals Presents Corporate Update on Neurology-Focused Pipeline at the Jefferies 2019 Healthcare Conference
05/06/2019
Company Highlights Recent Regulatory Feedback Guiding the Clinical Development of XEN901 into Pediatric SCN8A-EE Patients Webcast of Conference Presentation at 11:00 am ET Today BURNABY, British Columbia, June 05, 2019 [...]
Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph.D. to the Position of Chief Medical Officer
05/06/2019
Pittsburgh, June 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , today announced that Anthony O. Caggiano, M.D., Ph.D. has joined the Company as chief medical officer (CMO). Cognition Therapeutics is a [...]
RTI Surgical® Wins 2019 MedTech Breakthrough Award for TETRAfuse® 3D Technology
05/06/2019
Awards Program Recognizes Outstanding Health and Medical Technology Products and Companies DEERFIELD, Ill., June 05, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company [...]
Engage Therapeutics and Clinical Trial Network of Houston Host New York Times Bestselling Author Kurt Eichenwald for Inspiring Discussion about Overcoming Epilepsy
05/06/2019
Author of “A Mind Unraveled: A Memoir” at Crowne Plaza Houston Near Reliant Medical at 7 p.m. on June 13 HOUSTON, June 05, 2019 (GLOBE NEWSWIRE) -- New York Times bestselling author Kurt Eichenwald will be at Crowne [...]
Quotient Limited to Participate in the Raymond James Life Sciences and MedTech Conference
05/06/2019
JERSEY, Channel Islands, June 05, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present [...]
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting
05/06/2019
- Data demonstrated that oat avenanthramides supplementation could inhibit molecules involved in the exercise induced inflammation process EDMONTON, Alberta, June 05, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“ [...]
Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Plaque Psoriasis
05/06/2019
Top-line data is anticipated in the first half of 2020 If PSOARING trials are successful, a New Drug Application (NDA) filing with the U.S. Food and Drug Administration (FDA) is anticipated in 2021 BASEL, Switzerland [...]
Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
05/06/2019
First U.S. Composition of Matter Patent Issued for Genetically Engineered Red Cell CAMBRIDGE, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company [...]
HempAmericana Announces New Agreement to Become Principal Supplier for Florida-based CBD Brand
05/06/2019
NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is excited to announce that the Company [...]
Gritstone Oncology to Present at Two Upcoming Investor Conferences in June
05/06/2019
EMERYVILLE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs
05/06/2019
GAITHERSBURG, Md., June 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its HepTcell and ALT-702 [...]
Sproutly Submits Amendment for Flower Sales License
05/06/2019
N O T FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia, June 05, 2019 (GLOBE NEWSWIRE) -- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“ Sproutly " or the “ Company [...]
Avricore Health announces private placement
05/06/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia, June 05, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company [...]
Evolus Accelerates Next Phase of U.S. Launch of Jeuveau™ with ‘#NEWTOX NOW’ Consumer Conversion Program
05/06/2019
NEWPORT BEACH, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced the launch of the ‘#NEWTOX NOW’ consumer conversion program following the rapid adoption of the company’s Jeuveau™ [...]
Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Clinical Trial of Repeat Doses of CNTX-4975 in Patients with Moderate to Severe Osteoarthritis Knee Pain
05/06/2019
BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced completion of [...]

Pages